Literature DB >> 16051806

RNAs in the virion of Kaposi's sarcoma-associated herpesvirus.

Jill Bechtel1, Adam Grundhoff, Don Ganem.   

Abstract

De novo infection of cultured cells with Kaposi's sarcoma-associated herpesvirus (KSHV) typically results in a latent infection. Recently, however, it has been reported that a subset of lytic mRNAs can be detected in cells shortly after KSHV infection; this expression is transient and eventually subsides, leading to latent infection (H. H. Krishnan et al., J. Virol 78:3601-3620, 2004). Since it has been shown that viral RNAs can be packaged into other herpesvirus virions, we sought to determine if KSHV virions contained RNAs and, if so, whether these RNAs contributed to the pool of lytic transcripts detected immediately after infection. Using DNA microarray, reverse transcription (RT)-PCR, and Northern blotting analyses, we identified 11 virally encoded RNAs in KSHV virions. These corresponded in size to the full-length mRNAs found in cytoplasmic RNA, and at least one was directly demonstrated to be translated upon infection in the presence of actinomycin D. Ten of these RNAs correspond to transcripts reported by Krishnan et al. at early times of infection, representing ca. 30% of such RNAs. Thus, import of RNAs in virions can account for some but not all of the early-appearing lytic transcripts. Quantitative RT-PCR analysis of infected-cell RNA demonstrated that most of the virion RNAs were very abundant at late times of infection, consistent with nonspecific incorporation during budding. However, the intracellular levels of one virion mRNA, encoding the viral protease, were much lower than those of transcripts not packaged in the virus particle, strongly suggesting that it may be incorporated by a specific mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051806      PMCID: PMC1182685          DOI: 10.1128/JVI.79.16.10138-10146.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions.

Authors:  M T Sciortino; M Suzuki; B Taddeo; B Roizman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.

Authors:  D M Ciufo; J S Cannon; L J Poole; F Y Wu; P Murray; R F Ambinder; G S Hayward
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Authors:  J S Cannon; D Ciufo; A L Hawkins; C A Griffin; M J Borowitz; G S Hayward; R F Ambinder
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).

Authors:  Jean Chang; Don Ganem
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

6.  Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process.

Authors:  A E Greijer; C A Dekkers; J M Middeldorp
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells.

Authors:  Shaw M Akula; Naranatt P Pramod; Fu Zhang Wang; Bala Chandran
Journal:  Cell       Date:  2002-02-08       Impact factor: 41.582

9.  De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

Authors:  Michael Lagunoff; Jill Bechtel; Eleni Venetsanakos; Anne-Marie Roy; Nancy Abbey; Brian Herndier; Martin McMahon; Don Ganem
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover.

Authors:  Britt Glaunsinger; Don Ganem
Journal:  Mol Cell       Date:  2004-03-12       Impact factor: 17.970

View more
  47 in total

1.  Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.

Authors:  Cyprian C Rossetto; Gregory S Pari
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions.

Authors:  Cui-Qing Yang; Ling-Feng Miao; Xing Pan; Cong-Cong Wu; Simon Rayner; Edward S Mocarski; Han-Qing Ye; Min-Hua Luo
Journal:  Arch Virol       Date:  2013-07-25       Impact factor: 2.574

Review 3.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 4.  Making sense of antisense: seemingly noncoding RNAs antisense to the master regulator of Kaposi's sarcoma-associated herpesvirus lytic replication do not regulate that transcript but serve as mRNAs encoding small peptides.

Authors:  Yiyang Xu; Don Ganem
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection.

Authors:  John West; Blossom Damania
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

6.  MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions.

Authors:  Xianzhi Lin; Xiaofan Li; Deguang Liang; Ke Lan
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

7.  Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone.

Authors:  Kevin F Brulois; Heesoon Chang; Amy Si-Ying Lee; Armin Ensser; Lai-Yee Wong; Zsolt Toth; Sun Hwa Lee; Hye-Ra Lee; Jinjong Myoung; Don Ganem; Tae-Kwang Oh; Jihyun F Kim; Shou-Jiang Gao; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

8.  The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells.

Authors:  Lei Chen; Michael Lagunoff
Journal:  Virology       Date:  2006-10-30       Impact factor: 3.616

Review 9.  Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells.

Authors:  Bala Chandran
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

Review 10.  Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.

Authors:  Kevin Brulois; Jae U Jung
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.